Science & medicine news
-
James R. Downing, M.D., recognized as one of Modern Healthcare’s 100 Most Influential People in Healthcare
St. Jude CEO James R. Downing MD is currently leading the $12.9 billion six-year strategic plan, the largest investment in its 60-year history to advance the study and treatment of pediatric cancer and other catastrophic diseases.
-
St. Jude ‘Wunderkind’ honored by STAT for work with synthesized organic molecules
Daniel J. Blair, PhD, wins award for early-career scientists working on breakthrough discoveries in health, medicine and science.
-
‘Highly cited’ St. Jude scientists demonstrate influence in research
The list is based on papers ranked in the top 1% by citations— how often a research paper is referenced by other investigators in their work.
-
Model demonstrates how RNA splicing defects contribute to Alzheimer’s disease
St. Jude scientists studied the role of RNA splicing defects in Alzheimer’s disease, revealing degeneration and toxicity caused by neuron hyperexcitability.
-
Three of the world’s top research institutions join forces to drive progress against pediatric cancer
The Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute and St. Jude announced the largest academic collaboration of its kind.
-
A link between hypoxia and fetal hemoglobin provides hope for sickle cell disease
Cellular response to low oxygen also increases fetal hemoglobin expression in adults, which could lead to novel treatments for some genetic anemias.